Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2012
02/09/2012WO2012019128A1 Vegf antagonist compositions and uses thereof
02/09/2012WO2012019061A2 Novel effectors and methods of use
02/09/2012WO2012018866A2 Methods and compositions for the diagnosis and treatment of breast cancer
02/09/2012WO2012017439A2 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
02/09/2012WO2012017273A1 A sequence specific for phytoplasma causing bois noir (bn), uses thereof and bn diagnostic kits
02/09/2012WO2012017256A2 Scaffold peptides
02/09/2012WO2012017230A1 Vaccine
02/09/2012WO2012017208A1 Methods and compounds for the diagnosis and treatment of
02/09/2012WO2012017067A1 Plants resistant to pathogens and methods for production thereof
02/09/2012WO2012017058A1 Improved recombinant human follicle-stimulating hormone
02/09/2012WO2012016984A1 Method of producing and purifying an active soluble sialyltransferase
02/09/2012WO2012016973A1 Invention related to contact allergens
02/09/2012WO2012016960A1 Genomics of actinoplanes utahensis
02/09/2012WO2012016595A1 β-HAIRPIN PEPTIDOMIMETICS
02/09/2012WO2012016576A1 Improved recombinant human follicle-stimulating hormone
02/09/2012WO2012016419A1 Glp-1 derivatives and uses thereof
02/09/2012WO2012016290A1 Modified hepatitis c virus proteins
02/09/2012WO2011108794A3 Gene regulating cytokinesis, plants transformed with the gene, and method for regulating growth of plants using same
02/09/2012US20120036600 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
02/09/2012US20120036598 Plants with improved morphogenesis and method of constructing the same
02/09/2012US20120036590 Interferon-like protein zcyto21
02/09/2012US20120036589 Vaccine
02/09/2012US20120035350 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v
02/09/2012US20120035347 Interferon-alfa sensitivity biomarkers
02/09/2012US20120035346 Luminescent compounds
02/09/2012US20120035344 Nucleophilic catalysts for oxime linkage
02/09/2012US20120035321 Compounds and medical devices activated with solvophobic linkers
02/09/2012US20120035320 Polyacridine nucleic acid delivery peptide complexes
02/09/2012US20120035112 Neuronal differentiation-inducing peptide and use thereof
02/09/2012US20120035110 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE
02/09/2012US20120035109 Follicle stimulating hormone superagonists
02/09/2012US20120035106 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
02/09/2012US20120035104 Insulin derivatives
02/09/2012US20120035101 Long-acting growth hormone and methods of producing same
02/09/2012US20120035100 Satiation peptide administration
02/09/2012US20120035099 Fgf21 analogues and derivatives
02/09/2012US20120035095 Orally administered peptides synergize statin activity
02/09/2012US20120035094 F11 receptor (f11r) antagonists as therapeutic agents
02/09/2012US20120035073 Compositions and methods for the treatment of immune related diseases
02/09/2012US20120034691 Genetically encoded calcium indicators and methods of use
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same
02/09/2012US20120034671 Protein Matrix For Light-Initiated Electron Transfer
02/09/2012US20120034657 Thrombopoietic compounds
02/09/2012US20120034653 Trophic Conversion of Obligate Phototrophic Algae Through Metabolic Engineering
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034643 Fluorescent protein
02/09/2012US20120034630 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD)
02/09/2012US20120034265 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034264 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034259 Antigen delivery vectors and constructs
02/09/2012US20120034258 Polypeptides and immunizing compounds containing gram positive polypeptides and methods of use
02/09/2012US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
02/09/2012US20120034256 Hcv vaccines and methods for using the same
02/09/2012US20120034255 Conformationally stabilized hiv envelope immunogens
02/09/2012US20120034254 Antigenic cloaking and its use
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA
02/09/2012US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof
02/09/2012US20120034219 Uses of il-23 agonists and antagonists; related reagents
02/09/2012US20120034218 RBM3 in Colorectal Cancer Prognostics
02/09/2012US20120034196 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof (frank)
02/09/2012US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof
02/09/2012US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
02/09/2012DE102010039019A1 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use
02/09/2012DE102010039018A1 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting
02/09/2012DE102010039015A1 Linkerpeptid und seine Verwendung in Fusionsproteinen Linker peptide and its use in fusion proteins
02/09/2012DE102010033458A1 Use of lectin composition for e.g. prophylaxis and/or treatment of gonadotropin releasing hormone-analogues-related adverse drug side effects, comprising emulsified lectin, and optionally further auxiliary substances and carrier substances
02/09/2012CA2840993A1 Modified hepatitis c virus proteins
02/09/2012CA2807749A1 Protein fusion constructs possessing thrombolytic and anticoagulant properties
02/09/2012CA2807440A1 Methods and compounds for the diagnosis and treatment of cancer
02/09/2012CA2807397A1 Method of producing and purifying an active soluble sialyltransferase
02/09/2012CA2807264A1 Genomics of actinoplanes utahensis
02/09/2012CA2807127A1 Covalent diabodies and uses thereof
02/09/2012CA2805134A1 Improved recombinant human follicle-stimulating hormone
02/08/2012EP2416159A1 Method for detecting antibody against sith-1 in biological sample
02/08/2012EP2415873A1 Optimized non-canonical zinc finger proteins
02/08/2012EP2415872A1 Optimized non-canonical zinc finger proteins
02/08/2012EP2415783A1 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
02/08/2012EP2415782A1 Compounds stimulating undesirable cellular adhesion and applications thereof
02/08/2012EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
02/08/2012EP2415780A1 Synthetic peptide and uses thereof
02/08/2012EP2415478A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
02/08/2012EP2414836A2 Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
02/08/2012EP2414520A2 Methods of modulating an immune response to a viral infection
02/08/2012EP2414510A2 Induced pluripotent stem cells
02/08/2012EP2414392A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
02/08/2012EP2414390A2 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
02/08/2012EP2414389A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides
02/08/2012EP2414388A1 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury
02/08/2012EP2414387A2 Compositions and methods related to protein a (spa) variants
02/08/2012EP2414386A2 Newcastle disease virus vectored avian vaccines
02/08/2012EP2414385A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
02/08/2012EP2414384A1 Control of copolymer compositions
02/08/2012EP2414383A1 C6orf167 peptides and vaccines containing the same
02/08/2012EP2414380A2 Method for purifying recombinant fsh
02/08/2012EP2414043A1 Bmp-alk3 antagonists and uses for promoting bone growth
02/08/2012EP2413975A1 Lipopeptide inhibitors of hiv-1
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 2916